Retinal Cells Services For Medical Specialties
-
Manufactured by Newcells Biotech Limitedbased in UNITED KINGDOM
In vitro retinal disease modelling for retinal therapy. Newcells offers a fast and reliable in vitro safety and efficacy service for the evaluation of novel compounds for retinal therapy using complex human retinal organoid or RPE models developed in house. Both models are iPSC derived allowing gene-edited lines to be engineered using CRISPR/Cas9 for direct comparison between WT and mutant ...
-
Manufactured by Newcells Biotech Limitedbased in UNITED KINGDOM
Accelerated in vitro evaluation of retinal toxicity. Newcells offers a fast and reliable retinal drug toxicity in vitro testing service using complex models developed in house: retinal organoids and RPE. The retinal toxicity service evaluates how new compounds affect cell viability, following photoreceptor degeneration or loss of RPE barrier function including outer segment photoreceptor ...
-
based in GERMANY
The therapy is based on the knowledge that tissue is not completely destroyed when the optic nerve is damaged. Retinal ganglion cells may survive, but are malfunctioning. By applying gentle alternating pulses which are individually adapted to the patient, the Eyetronic Therapy stimulates the metabolism of the neurons in order to restore their function and to stop further cell degeneration. The ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you